{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:59:34Z","timestamp":1773255574712,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801406"],"award-info":[{"award-number":["81801406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Farnesol is a\n                      <jats:italic>Candida<\/jats:italic>\n                      -secreted quorum-sensing molecule of great interest as a potential antifungal agent for serious and hardly curable infections\u2014candidiasis, especially vulvovaginal candidiasis (VVC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The effect of farnesol on cellular morphology and viability and evaluated the production of Th1 (IL-2), Th2 (IL-4), proinflammatory (IL-6), chemotactic (IL-8), and Th17 (IL-17) cytokines in the culture supernatants of vaginal epithelial cell line (VK2) were evaluated. Moreover, we tested the inhibitory effect of farnesol on\n                      <jats:italic>C. albicans<\/jats:italic>\n                      adhesion. Scanning electron microscopy was conducted to observe any VK2 cell ultrastructural changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Only low concentrations (\u2264\u200950 \u00b5mol\/L) of farnesol did not affect the morphology and viability of the VK2 cells (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Farnesol reduced the adhesion of\n                      <jats:italic>C. albicans<\/jats:italic>\n                      to the VK2 cells. When treated with farnesol, statistical elevated levels of both IL-4 and IL-17 secreted by the infected VK2 cells were present in the culture supernatants (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Farnesol acts as a stimulator to up-regulate the Th17-type innate immune response, as well as Th2-type humoral immunity following\n                      <jats:italic>C. albicans<\/jats:italic>\n                      infection. Further research is required to select the optimal therapeutic dose to develop efficacious and safe mucosal immune adjuvant for treating VVCs.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12866-023-02987-7","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T03:02:27Z","timestamp":1694142147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The fungal quorum-sensing molecule, farnesol, regulates the immune response of vaginal epithelial cells against Candida albicans"],"prefix":"10.1186","volume":"23","author":[{"given":"Ting","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Yuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Hui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Guang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Nan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"issue":"6","key":"2987_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/myc.13248","volume":"64","author":"A Farr","year":"2021","unstructured":"Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W. Guideline: Vulvovaginal candidosis (AWMF 015\/072, level S2k). Mycoses. 2021;64(6):583\u2013602.","journal-title":"Mycoses"},{"issue":"9","key":"2987_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1056\/NEJMoa033114","volume":"351","author":"JD Sobel","year":"2004","unstructured":"Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C 3rd, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876\u201383.","journal-title":"N Engl J Med"},{"issue":"10","key":"2987_CR3","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/infdis\/jiz365","volume":"220","author":"E Roselletti","year":"2019","unstructured":"Roselletti E, Perito S, Sabbatini S, Monari C, Vecchiarelli A. Vaginal epithelial cells discriminate between yeast and hyphae of Candida albicans in Women who are colonized or have vaginal candidiasis. J Infect Dis. 2019;220(10):1645\u201354.","journal-title":"J Infect Dis"},{"issue":"2","key":"2987_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/microorganisms8020144","volume":"8","author":"D Rosati","year":"2020","unstructured":"Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent Vulvovaginal Candidiasis: an immunological perspective. Microorganisms. 2020;8(2):144.","journal-title":"Microorganisms"},{"issue":"1","key":"2987_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13568-016-0281-1","volume":"6","author":"T Li","year":"2016","unstructured":"Li T, Niu X, Zhang X, Wang S, Liu Z. Baofukang suppository promotes the repair of vaginal epithelial cells in response to Candida albicans. AMB Express. 2016;6(1):109.","journal-title":"AMB Express"},{"issue":"11","key":"2987_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1086\/324532","volume":"184","author":"MM Barousse","year":"2001","unstructured":"Barousse MM, Steele C, Dunlap K, Espinosa T, Boikov D, Sobel JD, Fidel PL Jr. Growth inhibition of Candida albicans by human vaginal epithelial cells. J Infect Dis. 2001;184(11):1489\u201393.","journal-title":"J Infect Dis"},{"key":"2987_CR7","doi-asserted-by":"publisher","unstructured":"Jenul C, Horswill AR. Regulation of Staphylococcus aureus Virulence. Microbiol Spectr. 2019;7(2). https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0031-2018.","DOI":"10.1128\/microbiolspec.GPP3-0031-2018"},{"key":"2987_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.micres.2018.03.007","volume":"210","author":"SA Padder","year":"2018","unstructured":"Padder SA, Prasad R, Shah AH. Quorum sensing: a less known mode of communication among fungi. Microbiol Res. 2018;210:51\u20138.","journal-title":"Microbiol Res"},{"issue":"11","key":"2987_CR9","first-page":"6988","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, He H, Liu J, Xie S, Han J. Inhibiting roles of farnesol and HOG in morphological switching of Candida albicans. Am J Transl Res. 2020;12(11):6988\u20137001.","journal-title":"Am J Transl Res"},{"issue":"4","key":"2987_CR10","first-page":"3201","volume":"19","author":"S Sebaa","year":"2019","unstructured":"Sebaa S, Boucherit-Otmani Z, Courtois P. Effects of tyrosol and farnesol on Candida albicans biofilm. Mol Med Rep. 2019;19(4):3201\u20139.","journal-title":"Mol Med Rep"},{"key":"2987_CR11","doi-asserted-by":"crossref","unstructured":"Leonhardt I, Spielberg S, Weber M, Albrecht-Eckardt D, Bl\u00e4ss M, Claus R et al. (2015). The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. mBio 6, e00143.","DOI":"10.1128\/mBio.00143-15"},{"issue":"10","key":"2987_CR12","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1128\/EC.4.10.1654-1661.2005","volume":"4","author":"C Westwater","year":"2005","unstructured":"Westwater C, Balish E, Schofield DA. Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance. Eukaryot Cell. 2005;4(10):1654\u201361.","journal-title":"Eukaryot Cell"},{"key":"2987_CR13","doi-asserted-by":"crossref","unstructured":"Robbins N, Wright GD, Cowen LE. Antifungal drugs: the current armamentarium and development of New Agents. Microbiol Spectr. 2016;4(5).","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"issue":"2","key":"2987_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.20081463","volume":"206","author":"HR Conti","year":"2009","unstructured":"Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206(2):299\u2013311.","journal-title":"J Exp Med"},{"issue":"6","key":"2987_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1348-0421.2009.00128.x","volume":"53","author":"S Abe","year":"2009","unstructured":"Abe S, Tsunashima R, Iijima R, Yamada T, Maruyama N, Hisajima T, Abe Y, Oshima H, Yamazaki M. Suppression of anti-Candida activity of macrophages by a quorum-sensing molecule, farnesol, through induction of oxidative stress. Microbiol Immunol. 2009;53(6):323\u201330.","journal-title":"Microbiol Immunol"},{"issue":"3","key":"2987_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/13543776.2020.1718653","volume":"30","author":"GA Delmondes","year":"2020","unstructured":"Delmondes GA, Santiago Lemos IC, Dias DQ, Cunha GLD, Ara\u00fajo IM, Barbosa R, Coutinho HDM, Felipe CFB, Barbosa-Filho JM, Lima NTR, De Menezes IRA, Kerntopf MR. Pharmacological applications of farnesol (C15H26O): a patent review. Expert Opin Ther Pat. 2020;30(3):227\u201334.","journal-title":"Expert Opin Ther Pat"},{"issue":"27","key":"2987_CR17","doi-asserted-by":"publisher","first-page":"25254","DOI":"10.1074\/jbc.M011552200","volume":"276","author":"MM Wright","year":"2001","unstructured":"Wright MM, Henneberry AL, Lagace TA, Ridgway ND, McMaster CR. Uncoupling farnesol-induced apoptosis from its inhibition of phosphatidylcholine synthesis. J Biol Chem. 2001;276(27):25254\u201361.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"2987_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.abb.2005.10.017","volume":"448","author":"A Hemmerlin","year":"2006","unstructured":"Hemmerlin A, Reents R, Mutterer J, Feldtrauer JF, Waldmann H, Bach TJ. Monitoring farnesol-induced toxicity in tobacco BY-2 cells with a fluorescent analog. Arch Biochem Biophys. 2006;448(1\u20132):93\u2013103.","journal-title":"Arch Biochem Biophys"},{"issue":"2\u20133","key":"2987_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cbi.2005.02.006","volume":"152","author":"TL Horn","year":"2005","unstructured":"Horn TL, Long L, Cwik MJ, Morrissey RL, Kapetanovic IM, McCormick DL. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol. Chem Biol Interact. 2005;152(2\u20133):79\u201399.","journal-title":"Chem Biol Interact"},{"issue":"9","key":"2987_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/yea.1389","volume":"23","author":"S Saidi","year":"2006","unstructured":"Saidi S, Luitaud C, Rouabhia M. In vitro synergistic effect of farnesol and human gingival cells against Candida albicans. Yeast. 2006;23(9):673\u201387.","journal-title":"Yeast"},{"issue":"2","key":"2987_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1128\/IAI.70.2.577-583.2002","volume":"70","author":"C Steele","year":"2002","unstructured":"Steele C, Fidel PL Jr. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun. 2002;70(2):577\u201383.","journal-title":"Infect Immun"},{"issue":"2","key":"2987_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1095\/biolreprod60.2.508","volume":"60","author":"RN Fichorova","year":"1999","unstructured":"Fichorova RN, Anderson DJ. Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod. 1999;60(2):508\u201314.","journal-title":"Biol Reprod"},{"issue":"11","key":"2987_CR23","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1038\/jid.2008.139","volume":"128","author":"K Eyerich","year":"2008","unstructured":"Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, Ring J, Traidl-Hoffmann C. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol. 2008;128(11):2640\u20135.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2987_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1369-5274(99)80064-2","volume":"2","author":"L Romani","year":"1999","unstructured":"Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol. 1999;2(4):363\u20137.","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"2987_CR25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1567-1364.2010.00620.x","volume":"10","author":"F De Bernardis","year":"2010","unstructured":"De Bernardis F, Santoni G, Boccanera M, Lucciarini R, Arancia S, Sandini S, Amantini C, Cassone A. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes. FEMS Yeast Res. 2010;10(4):432\u201340.","journal-title":"FEMS Yeast Res"},{"issue":"8","key":"2987_CR26","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1128\/iai.65.8.3399-3405.1997","volume":"65","author":"F De Bernardis","year":"1997","unstructured":"De Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect Immun. 1997;65(8):3399\u2013405.","journal-title":"Infect Immun"},{"issue":"12","key":"2987_CR27","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1128\/IAI.70.12.7073-7080.2002","volume":"70","author":"M Rouabhia","year":"2002","unstructured":"Rouabhia M, Ross G, Pag\u00e9 N, Chakir J. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun. 2002;70(12):7073\u201380.","journal-title":"Infect Immun"},{"issue":"1","key":"2987_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2958.2007.06013.x","volume":"67","author":"A Davis-Hanna","year":"2008","unstructured":"Davis-Hanna A, Piispanen AE, Stateva LI, Hogan DA. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis. Mol Microbiol. 2008;67(1):47\u201362.","journal-title":"Mol Microbiol"},{"issue":"4","key":"2987_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/EC.00321-09","volume":"9","author":"A Deveau","year":"2010","unstructured":"Deveau A, Piispanen AE, Jackson AA, Hogan DA. Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the ras-cyclic AMP signaling pathway. Eukaryot Cell. 2010;9(4):569\u201377.","journal-title":"Eukaryot Cell"},{"issue":"10","key":"2987_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1128\/EC.00144-12","volume":"11","author":"AK Lindsay","year":"2012","unstructured":"Lindsay AK, Deveau A, Piispanen AE, Hogan DA. Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans. Eukaryot Cell. 2012;11(10):1219\u201325.","journal-title":"Eukaryot Cell"},{"issue":"8","key":"2987_CR31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1128\/EC.05060-11","volume":"10","author":"RA Hall","year":"2011","unstructured":"Hall RA, Turner KJ, Chaloupka J, Cottier F, De Sordi L, Sanglard D, Levin LR, Buck J, M\u00fchlschlegel FA. The quorum-sensing molecules farnesol\/homoserine lactone and dodecanol operate via distinct modes of action in Candida albicans. Eukaryot Cell. 2011;10(8):1034\u201342.","journal-title":"Eukaryot Cell"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02987-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02987-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02987-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:12:34Z","timestamp":1700277154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02987-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2987"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02987-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2506624\/v1","asserted-by":"object"}]},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}